A MRI study to elucidate the pathophysiology of neurological and psychiatric diseases
Not Applicable
Recruiting
- Conditions
- Patients with neurological and psychiatric diseases
- Registration Number
- JPRN-UMIN000037775
- Lead Sponsor
- Saitama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Not provided
Exclusion Criteria
Subjets with low IQ or low education level Subjects with brain injury with loss of consciousness Subjects with seevere physical condition, kidney failure, or thyroid dysfuntion. Subjects who are considered to inadequate for study participants by researchers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What neuroimaging biomarkers are being investigated in JPRN-UMIN000037775 for Alzheimer's and schizophrenia pathophysiology?
How does MRI-based assessment in JPRN-UMIN000037775 compare to standard diagnostic methods for Parkinson's and bipolar disorder?
What molecular pathways are linked to structural brain changes observed in JPRN-UMIN000037775's psychiatric disease cohort?
Are there specific MRI-related adverse events reported in JPRN-UMIN000037775 neurological disease participants?
What combination therapies show potential in JPRN-UMIN000037775 for targeting neuroinflammation in MS and depression?